At the end of this presentation, the participant will be able to:

• Define the rol of brachytherapy for cervical cancer 
• Analyze the results of alternatives to brachytherapy
• Discuss possible difficulties in light of new systemic attitudes (Interlace) 

At the end of this presentation, the participant will be able to:

• Enumerate the possible gains for this attitude 
• Analyze the step to acheive adaptation
• Explain 

At the end of this presentation, the participant will be able to:

• Analyze the relationship between brachytherapy's dose and the  immune system.
• Outline clinical trials using radiation and immunotherapy.
• Discuss the immunogenicity of brachytherpy.

At the end of this presentation, the participant will be able to:

• Identified particularities which makes a case challenging
• Explain evaluation of patient for GYN brachytherapy
• Discuss how to adress difficult GYN brachytherapy cases
• Discuss the difference between an MRI vs a Scan/MRI workflow

At the end of the talk, the participant will be able to :

• Explain AI in brachytherapy
• Discuss the potential of AI in brachytherapy
• Discribe steps of brachytherapy where AI could help the workflow

At the end of this presentation, the participant will be able to:

• Discuss possible unconscious bias in the database
• Discuss role of human judgment in AI
• Explain AI ethic issues

At the end of this presentation: the participant will be able to:

• Explain how legalisation can keep pace the technology changes 
• Enumerate the laws already in place
• Discuss futur legal need

At the end of this talk, the participant will be able to:

• Define the rationale for using biophysical models in brachytherapy
• Discuss the general utility of the TG-267 report and the radiobiological features
• Understand the potential clinical impact of the diverse temporal dose delivery patterns used in different brachytheray modalities.

At the end of this talk, the participant will be able to:

• Describe motion sensor tracking systems 
• Clarify dose received to personnel in an emergency situation
• Understand the necessity of these systems

At the end of this talk, the partiticant will be able to:

• Understand brachytherapy tracking thecnology
• Discuss the benefit of tracking in brachytherapy 
• Explain potential clinical workflow using tracking technology

At the end of this talk, the participant will be able to: 

• Discuss the benefit of Y-90
• Explain the rationnate for using this technology
• Understand potential clinical worflow

At the en of this talk, the participant wille be able to:

• Understand possible radionuclides used for brachytherapy 
• Describe Selenium-75 and its properties
• Explain the dosimetry of selenium-75 compare to iridum-192

At the end of this activity, the participant will be able to:

• Reconstruction of applicator and interstitial catheters on MRI only
• Plan a treatement
• Sum dose to evaluate combined EBRT and brachytherapy plan

At the end of this activity, the participant will be able to:

• Preparing the patient and planned the implant 
• Perform the implant
• Discuss Dosimetry
• Understand  possible complications and toxicities

At the end of this activity, the participant will be able to:

• Planned the implant according toturn on geometry and localisation
• Discuss dosimetric parameters
• Analyze the feasability of the implat

At the end of this activity, the participant will be able to:

• Understand the role of each member of the team 
• Discuss the benefit of an efficient workflow 
• Identify the strengths of an integrated team

At the end of this activity, the participant will be able to:

• Recognize limitation due to anatomy relationships 
• Discuss dosimetry accommodation

At the end of the presentation, the participant will be able to: 

• List the different lung tumors and their locallisation which are amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetry parameters

At the end of this activity, the participant will be able to:

• Understand the ethymology of theses cancers
• Discuss the use of brachytherapy  in this context
• Analyze technique and dosimetry parameters

At the end of the presentation, the participant will be able to: 

• Understand different consideration according to localization of tongue tumor
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetry parameters 

At the end of this presentation, the participant will be able to: 

• List the different pediatric tumors amenable to brachytherapy
• Understand the particularities of brachytherapy's workflow for pediatric patient
• Analyze technique and considerations for pediatric brachytherapy

At the end of this presentation, the participant will be able to:

• Undesrtand the particularities of brachytherapy for biliary tract cancer
• Discuss dosimetry and applicators
• Analyze the feasibility of the implant

At the end of this presentation, the participant will be able to:

• Discuss the best pain control strategies for a given patient
• Personalize anesthesia to the tumor localization and to the patient

At the end of this presentations, the participation will be able to:

• Discuss the requirement for access to GYN  brachytherapy
• Understand possible access to image guided brachytherapy
• Analyze the encountered difficulties.

At the end of this presentation, the participant will be able to:

• Explain the difference and indications of each technic
• Discuss the long term results of each
• Determine the optimal lowest PSA value after

At the end of this presentation, the participant will be able to:

• Discuss the definition of recurrence
• Determine the optimal technique for reirradiation
• Analyze the toxicity patterns of the technics

At the end of this presentation, the participant will be able to:

• Understand the key radiobiological features of HDR dose fractionation
• Discuss the clinical implications of HDR fractionation on tumor and normal tissues in HDR brachytherapy
• Determine potential strategies to optimize HDR dose fractionation and therapeutic ratio